Vir Biotechnology Company

Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases.
Technology: Cell-based gene therapy
Industry: Public
Headquarters: San Francisco, California, United States
Founded Date: 2016-04-07
Employees Number: 101-250
Funding Status: IPO
Investors Number: 6
Total Funding: 793600000
Estimated Revenue: $1B to $10B
Last Funding Date: 2020-04-07
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership